Microbot Medical Spotlights Endovascular Robotics at SRS Annual Meeting
Event summary
- Microbot Medical to present at the Society of Robotic Surgery Annual Meeting on July 25, 2026.
- CEO Harel Gadot will discuss endovascular robotic market trends during a livestreamed panel.
- Company recently won Innovative Start-Up Award from Surgical Robotics Technology (SRT).
- LIBERTY® Endovascular Robotic System gaining adoption at leading U.S. academic centers.
The big picture
Microbot Medical's participation in the Society of Robotic Surgery Annual Meeting underscores the growing importance of endovascular robotics within the broader robotic surgery landscape. The company's recent FDA clearance and adoption at academic centers position it as a key player in transforming peripheral endovascular procedures through advanced robotic technology.
What we're watching
- Adoption Pace
- The pace at which the LIBERTY System gains traction in academic centers will determine its market penetration.
- Competitive Positioning
- How Microbot differentiates itself among other medical robotics companies showcased at SRS.
- Regulatory Impact
- Whether the FDA clearance and ongoing regulatory environment will support further commercialization efforts.
Related topics